Company Update AstraZeneca Pharma India Ltd - 506820 - Statement Of Investor Complaints For The Quarter Ended March 2021 BSE India No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0330 Name of the Signatory :- PRATAP RUDRADesignation :- Company Secretary and Compliance Officer